United States

Molecular Templates Inc (MTEM.OQ)

MTEM.OQ on NASDAQ Stock Exchange Capital Market

3:59pm EST
Change (% chg)

$-0.08 (-1.10%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Chart for


Molecular Templates, Inc., formerly Threshold Pharmaceuticals, Inc., is a clinical-stage biotechnology company. The Company is engaged in the discovery and development of therapeutic and diagnostic agents that selectively target tumor cells for the treatment of patients living with cancer. The Company also focused on the... (more)


Beta: 3.12
Market Cap(Mil.): $195.80
Shares Outstanding(Mil.): 26.90
Dividend: --
Yield (%): --


  Industry Sector
P/E (TTM): -- 185.97 15.71
EPS (TTM): -- -- --
ROI: -- -11.84 31.93
ROE: -- -36.93 16.16

BRIEF-Molecular Templates appoints Adam Cutler as CFO

* Molecular Templates strengthens management team with appointment of Adam Cutler as Chief Financial Officer

Nov 14 2017

BRIEF-Molecular Templates Q3 loss per share $0.62

* Molecular Templates, Inc. Reports third quarter 2017 financial results

Nov 14 2017

BRIEF-AbCheck and Molecular Templates collaborate to discover therapeutic oncology leads

* Says Abcheck will use Absieve discovery platform to deliver antibodies against biological targets selected by Molecular Templates​

Oct 25 2017

BRIEF-Molecular Templates files for sale of 11.6 mln shares of common stock by selling stockholders‍​

* Molecular Templates Inc - files for sale of 11.6 million shares of common stock by selling stockholders - sec filing‍​ Source text: (http://bit.ly/2x68onC) Further company coverage:

Sep 15 2017

BRIEF-Molecular Templates Inc files to say it raised $20 mln in equity financing‍​

* Molecular Templates Inc files to say it raised $20 million in equity financing‍​ Source text (http://bit.ly/2i1OaYC) Further company coverage:

Aug 15 2017

BRIEF-SHV Management Services reports 32.6 pct stake in Molecular Templates

* SHV Management Services reports 32.6 percent stake in molecular templates as of Aug 1 - SEC filing Source text: (http://bit.ly/2w4gAXS) Further company coverage:

Aug 14 2017

BRIEF-Takeda Pharmaceutical Co reports 10.9 pct stake in Molecular Templates - SEC Filing‍​

* Takeda Pharmaceutical Company reports 10.9 percent stake in Molecular Templates Inc as of August 1, 2017 - SEC Filing‍​ Source text: (http://bit.ly/2vTAtQL) Further company coverage:

Aug 10 2017

BRIEF-Takeda Pharmaceutical and Molecular Templates announce research and licensing collaboration

* Takeda Pharmaceutical and molecular templates announce multi-target research and licensing collaboration to develop next-generation oncology therapies​

Aug 03 2017


Earnings vs. Estimates